However, treatment of cells with the combination of mL4-3 and L1-7(N) modulated tumor-cell phenotype, increasing the surface expression (either percentage or MFI) of CEA, MUC-1, ICAM-1, Fas, Trail-R1, Trail-R2, and calreticulin (Table 1). This evidence concerns the gene TNFRSF10A and neoplasm.